» Articles » PMID: 36684570

Gender, Ethnic, and Socioeconomic Differences in Access to Catheter Ablation Therapy in Patients with Atrial Fibrillation

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Female patients, patients from racial minorities, and patient with low socioeconomic status have been noted to have less access to catheter ablation for atrial fibrillation.

Methods: This is a cross-sectional, retrospective study using a large population database (Explorys) to evaluate the gender, racial and socioeconomic differences in access of catheter ablation therapy in patient with atrial fibrillation.

Results: A total of 2.2 million patients were identified as having atrial fibrillation and 62,760 underwent ablation. Females had ablation in 2.1% of cases while males received ablation in 3.4% of cases. Caucasians had ablation in 3.3% of cases, African Americans in 1.5% of cases and other minorities in 1.2% of cases. Individuals on medicaid underwent ablation in 1.6% of cases, individuals on medicare and private insurance had higher rates (2.8 and 2.9%, respectively). Logistic regression showed that female patients (OR 0.608, CI 0.597-0.618, < 0.0001), patients who are African American (OR 0.483, CI 0.465-0.502, < 0.0001), or from other racial minorities (OR 0.343, CI 0.332-0.355, < 0.0001) were less likely to undergo ablation. Patient with medicare (OR 1.444, CI 1.37-1.522, < 0.0001) and private insurance (OR 1.572, CI 1.491-1.658, < 0.0001) were more likely to undergo ablation.

Conclusion: Female gender, racial minorities, low socioeconomic status are all associated with lower rates of catheter ablation in management of atrial fibrillation.

Citing Articles

Burden and predictors of mortality related to cardiogenic shock in the South Bronx Population.

Javed N, Itare V, Allu S, Penikilapate S, Pandey N, Ali N Am J Cardiovasc Dis. 2025; 14(6):355-367.

PMID: 39839567 PMC: 11744217. DOI: 10.62347/HYCA6457.


Atrial fibrillation in Black American patients: A review of genetics, risk factors, and outcomes.

Houmsse A, Malhotra N, Smith S, El Refaey M Heart Rhythm. 2024; 22(3):617-626.

PMID: 39515500 PMC: 11875954. DOI: 10.1016/j.hrthm.2024.10.074.


Social drivers in atrial fibrillation occurrence, screening, treatment, and outcomes: systematic-narrative hybrid review.

Frost L, Johnsen S, Benjamin E, Trinquart L, Vinter N Eur Heart J Suppl. 2024; 26(Suppl 4):iv50-iv60.

PMID: 39099579 PMC: 11292415. DOI: 10.1093/eurheartjsupp/suae073.

References
1.
Lee J, Kim T, Cha M, Park J, Park J, Kang K . Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population. Korean Circ J. 2018; 48(6):519-528. PMC: 5986752. DOI: 10.4070/kcj.2017.0389. View

2.
Golwala H, Jackson 2nd L, Simon D, Piccini J, Gersh B, Go A . Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J. 2016; 174:29-36. DOI: 10.1016/j.ahj.2015.10.028. View

3.
Durrani A, Soma S, Althouse A, Leef G, Qin D, Saba S . Impact of Race on Outcome of Patients Undergoing Rhythm Control of Atrial Fibrillation. J Immigr Minor Health. 2017; 20(1):14-19. DOI: 10.1007/s10903-016-0545-5. View

4.
Andrade J, Deyell M, Lee A, Macle L . Sex Differences in Atrial Fibrillation. Can J Cardiol. 2018; 34(4):429-436. DOI: 10.1016/j.cjca.2017.11.022. View

5.
Essien U, Holmes D, Jackson 2nd L, Fonarow G, Mahaffey K, Reiffel J . Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. JAMA Cardiol. 2018; 3(12):1174-1182. PMC: 6583087. DOI: 10.1001/jamacardio.2018.3945. View